MK-7337

N/A

Report date: 2025/11/24 17:31:52

NME

Base Information

Drug NameMK-7337

Drug Alias NameMK-733711C-MK-7337

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Carbon > 11C +[5]

Mechanisms of ActionPositron-emission tomography enhancersAnti-Synuclein alpha

TargetsSynuclein alpha

Therapy Area/IndicationsParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMerck & Co Inc

China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co Inc

Inactive CompaniesN/A

Active IndicationsParkinson Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A